Journal article
Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa
Abstract
Haemophilia and its treatment interfere with patients' life, so health-related quality of life (HRQoL) should be assessed when evaluating treatments. This study investigated the HRQoL of patients with haemophilia A treated prophylactically with a new recombinant factor VIII. Two phase 3 trials investigated turoctocog alfa in patients with severe haemophilia A: one in children, one in adults and adolescents. HRQoL was a secondary endpoint …
Authors
Santagostino E; Lentz SR; Busk AK; Regnault A; Iorio A
Journal
Haemophilia, Vol. 20, No. 4, pp. 527–534
Publisher
Wiley
Publication Date
July 2014
DOI
10.1111/hae.12371
ISSN
1351-8216